Bionano Genomics (BNGO) Return on Sales (2017 - 2026)

Bionano Genomics' Return on Sales history runs 10 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 2.0% YoY), while the FY2025 annual figure was 0.01%, up 3.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Bionano Genomics, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2025 to a low of 0.12% in Q3 2023.
• A 5-year average of 0.04% and a median of 0.04% in 2023 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales dropped 8 bps in 2023 and grew 6 bps in 2025, its largest moves.
• Bionano Genomics' Return on Sales stood at 0.05% in 2022, then grew by 13 bps to 0.04% in 2023, then soared by 38 bps to 0.03% in 2024, then jumped by 60 bps to 0.01% in 2025, then dropped by 24 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison